Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Masitinib in Patients with Primary Progressive Multiple Sclerosis (PPMS) or Relapse-Free Secondary Multiple Sclerosis (SPMS)
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
Pharmacokinetics and metabolism of mitoxantrone. A review.
Multiple sclerosis prevalence in the United States commercially insured population.
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
Novel MS Drugs Advance
Autoantibodies and pain.
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Dimethyl fumarate for multiple sclerosis.
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis.

Pages